Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.2, 2008-02, pp. : 245-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias

By Blau Nenad

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1207-1218

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of Sapropterin in Patients with Phenylketonuria

By Feillet François

Clinical Pharmacokinetics, Vol. 47, Iss. 12, 2008-01 ,pp. : 817-825

Adis International

Access to resources Recommend Favorite

Sapropterin: A Review of its Use in the Treatment of Primary Hyperphenylalaninaemia

By Sanford Mark Keating Gillian M.

Drugs, Vol. 69, Iss. 4, 2009-01 ,pp. : 461-476

Adis International

Access to resources Recommend Favorite

Disorders of Tetrahydrobiopterin Metabolism and their Treatment

Current Drug Metabolism, Vol. 3, Iss. 2, 2002-04 ,pp. : 123-131

Bentham Science Publishers

Access to resources Recommend Favorite

Toxic rather than neuropharmacological effect of Ternstroemia sylvatica fruits and identification of 28-O-[β-l-6-rhamnopyranosyl]-R₁-barrigenol as a new compound with toxic effects in mice*

By Balderas-López José Luis Alfaro-Romero Alejandro Monroy Amor López-Villafranco Ma. Edith Rivero-Cruz José Fausto Navarrete Andrés

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 51, Iss. 11, 2013-11 ,pp. : 1451-1458

Informa Healthcare

Access to resources Recommend Favorite